Clearbridge’s second batch of Sinopharm vaccines arrives in Singapore

The company’s first batch has been fully allocated in the country.

Clearbridge announced that the second batch of COVID-19 vaccines from Sinopharm has arrived in Singapore.

This development comes as the initial batch of vaccines from the company has been fully allocated in Singapore. These arrived on 28 August and were distributed by Medic Surgical & Laser Clinic, a subsidiary of the company.

The Royal Healthcare Specialists Center will also have access to this shipment under the Special Access Route approval from the Health Sciences Authority of Singapore.

Currently, the Sinopharm COVID-19 vaccine has been authorised for conditional and emergency use in several countries. These include the People’s Republic of China, the United Arab Emirates, Malaysia, Thailand, and Indonesia.

Follow the link for more news on

Clearbridge

vaccine roll-out

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia